Rangeley Capital, LLC
Q4 2025 13F Holdings
- Locationnew canaan, CT
- Num holdings
123
- Value ($000)
$120,412
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001517796
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
WARNER BROS DISCOVERY INC | COM SER A | 934423104 | $6.23M | 5 % | 216,000 | ||
GOLDEN ENTMT INC | COM | 381013101 | $5.71M | 5 % | 209,881 | ||
CALUMET INC | COM | 131428104 | $5.15M | 4 % | 259,300 | ||
PROTHENA CORP PLC | SHS | G72800108 | $5.01M | 4 % | 524,600 | ||
YEXT INC | COM | 98585N106 | $4.72M | 4 % | 585,360 | ||
ARVINAS INC | COM | 04335A105 | $4.69M | 4 % | 395,800 | ||
ARBUTUS BIOPHARMA CORP | COM | 03879J100 | $4.04M | 3 % | 840,000 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | $3.9M | 3 % | 54,000 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | $3.35M | 3 % | 1,287,829 | ||
KENNEDY-WILSON HOLDINGS INC | COM | 489398107 | $3.31M | 3 % | 342,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100